| Financial Year |
March 31 2023 |
| Monetary Funds |
5,508,180,261.97 |
| Held-for-trading Financial Assets |
974,897,430.42 |
| Notes Receivable |
873,401,368.95 |
| Accounts Receivable |
2,090,153,542.40 |
| Advances to Suppliers |
348,297,818.38 |
| Other Receivables |
1,472,738,008.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,691,969.53 |
| Dividend Receivable |
-- |
| Inventories |
4,923,487,671.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,131,788.69 |
| Other Current Assets |
2,422,116,387.74 |
| Total Current Assets |
18,755,697,105.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
800,400.00 |
| Long-term Equity Investment |
5,830,552,477.38 |
| Investment Properties |
1,411,935,815.98 |
| Fixed Assetes |
4,039,964,101.20 |
| Under-construction Projects |
1,415,725,086.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,081,992,209.96 |
| R&D expenses |
-- |
| Goodwill |
22,196,735.11 |
| Long-Term Deferred and Prepaid Expenses |
510,239,917.35 |
| Deferred Income Tax Assets |
1,279,102,703.17 |
| Other Non-Current Assets |
1,293,827,721.71 |
| Sub-Total of Non-Current Assets |
19,589,875,446.83 |
| Total Assets |
38,345,572,552.50 |
| Short-Term Loans |
7,065,682,875.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,055,892,081.93 |
| Accounts Payable |
2,301,879,604.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
164,854,050.74 |
| Taxes Payable |
193,156,126.51 |
| Interest Payable |
29,627,245.69 |
| Dividend Payable |
-- |
| Other payables |
1,593,870,928.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,447,600,623.73 |
| Other Current Liabilities |
78,098,011.79 |
| Sub-Total of Current Liabilities |
17,613,181,267.81 |
| Long-term Loans |
7,322,406,772.41 |
| Bonds Payable |
3,738,967,976.95 |
| Long-Term Accounts Payable |
7,491,941.30 |
| Special Payable |
-- |
| Estimatied Liabilities |
192,586,085.71 |
| Deferred Income Tax Liabilities |
261,413,172.81 |
| Other Non-Current Liabilities |
311,712,735.60 |
| Sub-Total of Non-Current Liabilities |
12,196,462,432.30 |
| Total Liabilities |
29,809,643,700.11 |
| Paid-In Capital(Or Share Stock) |
2,407,945,408.00 |
| Capital Surplus |
347,813,376.32 |
| Surplus Reserve |
1,244,180,364.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,791,941,933.35 |
| Minority Stockholder's Interest |
759,358,777.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,776,570,075.05 |
| Owner's Equity（Stockholder's Equity） |
8,535,928,852.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,345,572,552.50 |
